Is Eli Lilly (LLY) The Best Healthcare Stock to Buy According to Jim Cramer?

Jim Cramer has agelong been a believer successful Eli Lilly and Company (NYSE:LLY). In November, helium said connected CNBC that the institution is apt to deed the $1 trillion marketplace headdress milestone amid its weight-loss pill catalyst. LLY is simply a cardinal portion of Jim Cramer banal portfolio for 2026.

Eli Lilly and Company (NYSE:LLY) is preparing to motorboat its caller oral obesity drug, orforglipron, successful the United ​States arsenic aboriginal arsenic the 2nd 4th of ​this year, taxable to FDA approval, according to a Reuters report.

“This pill that they have, GLP-1, the thought that you’ll conscionable beryllium capable to get it for value loss, not comorbidity. People are opening to recognize possibly this happening is worthy acold more,” Cramer said successful November. “Eli Lilly is simply a large company. Dave Ricks (CEO), by the way, the institution does a batch of work. Dave Ricks is simply a truly unbelievable man. But what he’s truly driving is simply a institution that’s going to walk $1 trillion. Congratulations to him.”

Jensen Quality Growth Equity Strategy explained successful their Q4 missive wherefore LLY roseate successful Q4 and important points astir its incretin portfolio and prospects for expanded Medicare coverage. Read the missive successful item here.

Pixabay/Public domain

While we admit the imaginable of LLY arsenic an investment, we judge definite AI stocks connection greater upside imaginable and transportation little downside risk. If you're looking for an highly undervalued AI banal that besides stands to payment importantly from Trump-era tariffs and the onshoring trend, spot our escaped study connected the best short-term AI stock.

READ NEXT: 33 Stocks That Should Double successful 3 Years and Cathie Wood 2026 Portfolio: 10 Best Stocks to Buy. 

Disclosure: None. Follow Insider Monkey connected Google News.